\u201cIt has not proved possible to respond to the hon. Member in the time available before Prorogation.\u201d<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4053", "label" : {"_value" : "Biography information for Mrs Heather Wheeler"} } , "answeringMemberConstituency" : {"_value" : "South Derbyshire"} , "answeringMemberPrinted" : {"_value" : "Mrs Heather Wheeler"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T13:52:15.947Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tibet: Climate Change"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has had with his Chinese counterpart on the effect of climate change on Tibet.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294242"} , {"_about" : "http://data.parliament.uk/resources/1148119", "AnsweringBody" : [{"_value" : "Department for International Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148119/answer", "answerText" : {"_value" : "
The Department for International Trade (DIT) plays a critical role in promoting the UK as the natural choice for overseas investment. The Department provides support to inward investors who wish to set up in the UK.<\/p>
<\/p>
These services range from providing information, guidance and support on the UK business environment, to access to finance, talent and skills, visas and migration, research and innovation, and sector experts.<\/p>
<\/p>
DIT also provides an end-to-end service for investors, through initiatives such as the Strategic Relationship Management Programme, both in the UK and overseas, working with colleagues across government, in London, UK regions and Devolved Administrations. This suite of services helps investors prosper and succeed, which in turn leads them to reinvest further in the UK. The UK has the highest stock of FDI of any nation in Europe.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1482", "label" : {"_value" : "Biography information for Graham Stuart"} } , "answeringMemberConstituency" : {"_value" : "Beverley and Holderness"} , "answeringMemberPrinted" : {"_value" : "Graham Stuart"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T16:13:00.99Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "202"} , "answeringDeptShortName" : {"_value" : "International Trade"} , "answeringDeptSortName" : {"_value" : "International Trade"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Foreign Investment in UK"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Trade, what guidance his Department issues to foreign companies planning to invest in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294168"} , {"_about" : "http://data.parliament.uk/resources/1148120", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148120/answer", "answerText" : {"_value" : "
We take our duty of care to our personnel very seriously, but risk is inherent in many activities carried out by the Armed Forces. This risk is rendered as low as reasonably practicable during training by ensuring that its design and delivery are subject to strict safety procedures and rigorous risk analysis. Training programmes are also subject to internal or external assurance and audit inspections including by OFSTED.<\/p>
On 1 April 2015, we established the Defence Safety Authority which brings together the Defence Safety Regulators and the Accident Investigation Branch, providing independent assurance to the Secretary of State in accordance with his health, safety and environmental policy statement.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4485", "label" : {"_value" : "Biography information for Johnny Mercer"} } , "answeringMemberConstituency" : {"_value" : "Plymouth, Moor View"} , "answeringMemberPrinted" : {"_value" : "Johnny Mercer"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T13:31:33.727Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Forces: Training"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what steps he is taking to ensure the safety of recruits undertaking physical training courses.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294169"} , {"_about" : "http://data.parliament.uk/resources/1148121", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148121/answer", "answerText" : {"_value" : "
The Ministry of Defence (MOD) takes the health and wellbeing of its personnel very seriously. A Health and Wellbeing Strategy for all MOD employees, military and civilian, was published in mid-2015 (updated in August 2016) and is designed to provide guidance to the Chain of Command and civilian line managers on how to manage the health needs, both mental and physical, of their people. The aim is to maximise the number of people fit to work, managing people back to work after a period of sickness, so that they are fit and able to meet the requirements of Defence outputs, including operational effectiveness.<\/p>
Whilst the MOD records the medical employability and deployability of Service personnel, more specific information about the level of sickness absence among women - or men - in the Armed Forces is not held centrally. As at 1 May 2019, medical employability for the trained UK Armed Forces was 98 per cent, with a male:female split of 98:97% respectively.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4485", "label" : {"_value" : "Biography information for Johnny Mercer"} } , "answeringMemberConstituency" : {"_value" : "Plymouth, Moor View"} , "answeringMemberPrinted" : {"_value" : "Johnny Mercer"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T12:57:21.807Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Forces: Sick Leave"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what estimate he has made of level of sickness absence among women in the armed forces in the latest period for which figures are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294243"} , {"_about" : "http://data.parliament.uk/resources/1148122", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148122/answer", "answerText" : {"_value" : "
It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"} } , "answeringMemberConstituency" : {"_value" : "Richmond Park"} , "answeringMemberPrinted" : {"_value" : "Zac Goldsmith"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T16:31:31.54Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Birds: Pest Control"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the effectiveness of the general licences for bird control that were introduced in April 2019.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294170"} , {"_about" : "http://data.parliament.uk/resources/1148207", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148207/answer", "answerText" : {"_value" : "
It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T15:21:50.667Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Parkinson's Disease: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions his Department has had with health bodies on the findings of recent clinical trials for Terazosin and its potential effect of slowing down the progression of Parkinson's disease.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294171"} , {"_about" : "http://data.parliament.uk/resources/1148209", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148209/answer", "answerText" : {"_value" : "
Montelukast is effective in the treatment of asthma in adults, adolescents and children aged six months and older who are not adequately controlled on their usual/routine asthma medication and who need additional therapy. Montelukast also helps to prevent the narrowing of airways triggered by exercise. The benefits of montelukast have been shown to outweigh the risks in adults and children.<\/p>
The very rare risk (up to 1 in 10,000 people) of neuropsychiatric reactions in association with montelukast treatment has been known for some time and information about adverse reactions including hallucinations and suicidal thinking and behaviour (suicidality) are already included in the product information for montelukast.<\/p>
In September the Medicines and Healthcare Products Regulatory Agency published an article in Drug Safety Update to remind prescribers of the very rare risk of neuropsychiatric reactions with use of montelukast. The article outlines the risks and advises healthcare professionals to evaluate carefully the risks and benefits of continuing treatment with montelukast if neuropsychiatric reactions occur. Healthcare professionals are reminded to report any suspected adverse drug reactions associated with montelukast to the Yellow Card Scheme.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1481", "label" : {"_value" : "Biography information for Ms Nadine Dorries"} } , "answeringMemberConstituency" : {"_value" : "Mid Bedfordshire"} , "answeringMemberPrinted" : {"_value" : "Ms Nadine Dorries"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T15:07:26.883Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Montelukast: Side Effects"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of reports that doctors have been advised to warn asthma patients using the drug Montelukast of potential hallucinations and suicidal thoughts and other side-effects.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294172"} , {"_about" : "http://data.parliament.uk/resources/1148211", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148211/answer", "answerText" : {"_value" : "
It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T15:19:26.153Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Stargardt Disease"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people were diagnosed with Stargardt Disease in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294173"} , {"_about" : "http://data.parliament.uk/resources/1148212", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148212/answer", "answerText" : {"_value" : "
Decisions about treatment should always be based on patients\u2019 clinical needs. Clinical commissioning groups (CCGs) are required to commission healthcare services that meet the needs of their local population. To achieve this, they must assess local need, determining priorities and strategies, and commission services on behalf of their local population; overseeing those contracts to ensure high-quality care is provided.<\/p>
National Health Service commissioners are legally required to fund treatments recommended in National Institute for Health and Care Excellence technology appraisal and highly specialised technologies guidance.<\/p>
The future routine availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T14:46:07.017Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Glaucoma: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he plans to make the biodegradable implant that replaces eye drops for glaucoma available on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294174"} , {"_about" : "http://data.parliament.uk/resources/1148214", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1148214/answer", "answerText" : {"_value" : "
The Government committed in the NHS Long Term Plan published in January to modernise the Bowel Cancer Screening Programme (BCSP) to detect more cancers earlier. The plan will modernise the BCSP to detect more cancers earlier by lowering the starting age for bowel screening from 60 to 50.<\/p>
Further, the Faecal Immunochemical Test was rolled out in England in June 2019 following a UK National Screening Committee recommendation to replace the previously used Faecal Occult Blood test. This test is both more accurate and more acceptable so will contribute to saving many more lives from bowel cancer and, as an easier test for patients to use, is expected to improve take up rates by 7%, including among groups with low participation rates such as men, people from ethnic minority backgrounds and people in more deprived areas.<\/p>
In addition, we expect the Professor Sir Mike Richards\u2019 Review of Screening, due to be published soon, to identify additional opportunities to improve the uptake of bowel cancer screening.<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2019-10-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-08T14:49:34.33Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bowel Cancer: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent steps he has taken to improve diagnostic rates of the NHS bowel cancer test.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "294175"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpModified.=2019-10-08T11%3A29%3A09.484Z&min-date=2019-10-02&min-answer.questionFirstAnswered.=2019-05-21T13%3A46%3A00.197Z&creator.label=Biography+information+for+Jim+Shannon&min-ddpModified.=2019-09-09T16%3A47%3A06.991Z", "page" : 0, "startIndex" : 1, "totalResults" : 23, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }